Selected Lysosomal Enzyme Activities and the Oxidant-antioxidant Balance in Hyperbaric Oxygen Condition. - Trial NCT06401941
Access comprehensive clinical trial information for NCT06401941 through Pure Global AI's free database. This phase not specified trial is sponsored by Nicolaus Copernicus University and is currently Completed. The study focuses on Hyperbaric Oxygenation,Oxygen Toxicity,Antioxidants,Oxidative Stress. Target enrollment is 78 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Hyperbaric Oxygen Therapy
Interventional
procedure
Sponsor & Location
Nicolaus Copernicus University
Timeline & Enrollment
N/A
Apr 26, 2016
Dec 31, 2020
Primary Outcome
Thiobarbituric acid reactive substances (TBARS),Malondialdehyde (MDA),Conjugated dienes (CD),Catalase (CAT),Superoxide dismutase (SOD),Glutathione peroxidase (GPx)
Summary
The aim of the research project was to investigate the effects of hyperbaric oxygen (HBO)
 treatment on the redox equilibrium in individuals with different pathological conditions.
 Both hyperbaric oxygenation and the pathological condition are associated with redox
 imbalance (oxidative stress), however, HBO is successfully used in the treatment of chronic
 wounds, e.g., diabetic foot syndrome, as well as in sudden and acute hearing loss, e.g.,
 acute acoustic trauma or idiopathic sudden sensorineural hearing loss.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06401941
Non-Device Trial